The 2014 HIDA Influenza Vaccine Production & Distribution market brief provides new insights into the flu products supply chain, featuring information from the fourth annual “HIDA Flu Products Survey” of distributors conducted in April 2014. The survey demonstrates the key role that distributors will serve in the 2014-2015 flu season in helping healthcare facilities and patients access vaccines, hypodermic supplies, administration kits, diagnostic tests, and more.
The 2013–2014 influenza season was a moderately severe year, in which the influenza A (H3N2), 2009 influenza A (H1N1), and influenza B viruses circulated in the United States. The 2009 H1N1 viruses predominated most of the year, while the influenza B viruses came on stronger later in the season. The healthcare supply chain demonstrated flexibility and operational skill through 24-48 hour delivery and logistical expertise to ensure healthcare providers were well-supplied throughout the flu season.
Additionally, the 2014 Influenza Vaccine Production & Distribution market brief provides key information on;
Flu vaccine production, supply, and allocation
Patient and physician vaccination trends
Managing influenza with diagnostic resources
Manufacturing and distribution processes
New data on sites for patient vaccination
Medicare reimbursement guide
Quality reporting measures related to influenza vaccination.